Palvella Therapeutics, Inc.
Q3 2025 13F Holders
Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filers
100
Total reported value, excl. options
$534M
Compare 2025 Q3 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
Excl. options
Options only
All
Manager
Report Date
Value ($000)
Shares